We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
126
Sherwin-Williams
SHW
$79.8B
$225K 0.16%
647
-5
-0.8% -$1.59K
HIGH icon
127
Simplify Enhanced Income ETF
HIGH
$69.3M
$224K 0.16%
9,186
-65
-0.7% -$1.59K
BIIB icon
128
Biogen
BIIB
$29.5B
$223K 0.15%
1,035
-53
-5% -$12.4K
LIN icon
129
Linde
LIN
$237B
$222K 0.15%
478
-15
-3% -$6.5K
AFL icon
130
Aflac
AFL
$63.2B
$216K 0.15%
2,511
+25
+1% +$2.05K
UNP icon
131
Union Pacific
UNP
$176B
$215K 0.15%
876
+34
+4% +$8.37K
PEP icon
132
PepsiCo
PEP
$185B
$211K 0.15%
1,205
+4
+0.3% +$673
SNOW icon
133
Snowflake
SNOW
$95.1B
$208K 0.14%
1,286
-13
-1% -$2.52K
EL icon
134
Estee Lauder
EL
$30.3B
$203K 0.14%
+1,318
New +$187K
MRSH
135
Marsh
MRSH
$87.7B
$202K 0.14%
+979
New +$195K
VOD icon
136
Vodafone
VOD
$35.5B
$155K 0.11%
17,383
+1,962
+13% +$17K
PCT icon
137
PureCycle Technologies
PCT
$1.22B
$104K 0.07%
+16,656
New +$77.5K
CIM
138
Chimera Investment
CIM
$1.06B
$67.4K 0.05%
4,875
– –
HIO
139
Western Asset High Income Opportunity Fund
HIO
$347M
$60.3K 0.04%
15,466
+1
+0% +$4
KNDI
140
Kandi Technologies Group
KNDI
$73.4M
$31.8K 0.02%
15,000
– –
BIL icon
141
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
– –
-3,059
Closed -$280K
FAPR icon
142
FT Vest US Equity Buffer ETF April
FAPR
$1.26B
– –
-14,477
Closed -$506K
LEN icon
143
Lennar Class A
LEN
$20B
– –
-1,441
Closed -$208K
LGLV icon
144
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.18B
– –
-1,561
Closed -$226K
MDT icon
145
Medtronic
MDT
$107B
– –
-6,852
Closed -$565K
SGOV icon
146
iShares 0-3 Month Treasury Bond ETF
SGOV
$98.5B
– –
-4,827
Closed -$484K
WBD icon
147
Warner Bros
WBD
$64.8B
– –
-12,222
Closed -$139K
TGAA
148
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
– –
-1,656
Closed -$236K
2 3 4 5
6

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.